Liver Diseases  >>  Promacta (eltrombopag)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Promacta (eltrombopag) / Novartis
NCT00359463: Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Completed
1
33
US, RoW
eltrombopag
GlaxoSmithKline
Purpura, Thrombocytopaenic, Idiopathic
03/07
03/07
NCT00833378: Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.

Completed
1
40
US
Eltrombopag, Lopinavir/Ritonavir, Eltrombopag and Lopinavir/Ritonavir
GlaxoSmithKline
Hepatitis C
03/09
03/09

Download Options